200 related articles for article (PubMed ID: 23438512)
1. Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.
Johnson H; Lescarbeau RS; Gutierrez JA; White FM
J Proteome Res; 2013 Apr; 12(4):1856-67. PubMed ID: 23438512
[TBL] [Abstract][Full Text] [Related]
2. HGF-independent potentiation of EGFR action by c-Met.
Dulak AM; Gubish CT; Stabile LP; Henry C; Siegfried JM
Oncogene; 2011 Aug; 30(33):3625-35. PubMed ID: 21423210
[TBL] [Abstract][Full Text] [Related]
3. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
6. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
[TBL] [Abstract][Full Text] [Related]
7. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
Parr C; Ali AY
J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527
[TBL] [Abstract][Full Text] [Related]
8. ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.
Radtke S; Milanovic M; Rossé C; De Rycker M; Lachmann S; Hibbert A; Kermorgant S; Parker PJ
J Cell Sci; 2013 Jun; 126(Pt 11):2381-91. PubMed ID: 23549785
[TBL] [Abstract][Full Text] [Related]
9. MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.
Shi W; Song J; Wang W; Zhang Y; Zheng S
Mol Med Rep; 2017 Nov; 16(5):7329-7336. PubMed ID: 28944826
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
[TBL] [Abstract][Full Text] [Related]
11. EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.
Breindel JL; Haskins JW; Cowell EP; Zhao M; Nguyen DX; Stern DF
Cancer Res; 2013 Aug; 73(16):5053-65. PubMed ID: 23794705
[TBL] [Abstract][Full Text] [Related]
12. Endostar regulates EMT, migration and invasion of lung cancer cells through the HGF-Met pathway.
Shen Y; Chen Q; Li L
Mol Cell Probes; 2019 Jun; 45():57-64. PubMed ID: 31096000
[TBL] [Abstract][Full Text] [Related]
13. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
Reznik TE; Sang Y; Ma Y; Abounader R; Rosen EM; Xia S; Laterra J
Mol Cancer Res; 2008 Jan; 6(1):139-50. PubMed ID: 18234969
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling.
Li Y; Huang X; Zhong W; Zhang J; Ma K
Mol Cell Biochem; 2013 Oct; 382(1-2):83-92. PubMed ID: 23749170
[TBL] [Abstract][Full Text] [Related]
15. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.
Nakagawa T; Takeuchi S; Yamada T; Nanjo S; Ishikawa D; Sano T; Kita K; Nakamura T; Matsumoto K; Suda K; Mitsudomi T; Sekido Y; Uenaka T; Yano S
Mol Cancer Ther; 2012 Oct; 11(10):2149-57. PubMed ID: 22844075
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor activates several transduction pathways in rat pancreatic acini.
Aparicio IM; Garcia-Marin LJ; Andreolotti AG; Bodega G; Jensen RT; Bragado MJ
Biochim Biophys Acta; 2003 Dec; 1643(1-3):37-46. PubMed ID: 14654226
[TBL] [Abstract][Full Text] [Related]
18. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
Aasrum M; Ødegård J; Sandnes D; Christoffersen T
Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE
Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
